// Key Takeaways
  • Protein Risk: GLP-1 agonists reduce appetite dramatically — this can inadvertently drop protein intake below the muscle-preservation threshold
  • Modulate Intensity: Training intensity must be adjusted — energy availability is reduced, recovery is slower, and CNS fatigue accumulates faster
  • Nausea Windows: Gastroparesis from GLP-1s requires strategic pre-workout nutrition timing to avoid performance-killing nausea
  • Standard Programs Fail: Most personal training programs were NOT designed for GLP-1 patients — they can accelerate lean mass loss in this context
  • Physician Coordination: RxFit's GLP-1-adapted programming coordinates directly with your prescribing physician's plan

There is a medication revolution happening in Austin right now. In every Westlake kitchen, every Domain high-rise, every corporate wellness program in the city, GLP-1 agonists have become the conversation. Ozempic for weight loss. Wegovy for obesity. Zepbound and Mounjaro at the leading edge of dual-action therapy. The results are real, the adoption is accelerating — and the training world has not caught up.

Most personal trainers are working with GLP-1 patients using programs that were not designed for this biology. That mismatch has consequences. This article is a clinical briefing — what the physiology demands, what standard approaches get wrong, and what a properly adapted protocol looks like.

The GLP-1 Revolution

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a naturally occurring gut hormone that regulates blood sugar, slows gastric emptying, and signals satiety to the brain. The pharmaceutical versions are, by any clinical measure, the most effective weight-loss agents ever developed for non-surgical use.

Ozempic / Wegovy
Semaglutide
GLP-1 receptor agonist. Weekly injection. Ozempic (type 2 diabetes), Wegovy (chronic weight management).
Mounjaro / Zepbound
Tirzepatide
Dual GLP-1 + GIP receptor agonist. Weekly injection. Currently showing superior weight loss outcomes in clinical trials vs. semaglutide alone.
Victoza / Saxenda
Liraglutide
GLP-1 receptor agonist. Daily injection. Earlier-generation agent; less potent weight-loss profile but well-established safety data.
Rybelsus
Oral Semaglutide
First oral GLP-1 agent. Daily tablet. Increasing adoption among patients who prefer to avoid injections.

The scale of adoption in Austin's executive population is significant. In a city defined by high-performance culture and ambitious health optimization, GLP-1s have been embraced as a legitimate tool — not a shortcut. The question is not whether to use them. The question is whether the training program surrounding them is built for this specific biology.

How GLP-1s Change Your Training Biology

GLP-1 agonists create a constellation of physiological changes that fundamentally alter the training equation. Understanding these changes is the difference between a training program that protects your body and one that systematically dismantles it.

The Protein Crisis. GLP-1s are extraordinarily effective appetite suppressants. Patients on therapeutic doses routinely report that they have to actively remind themselves to eat. The problem is that when caloric intake drops dramatically, protein intake follows — often falling well below the minimum threshold for muscle protein synthesis.

For a 180 lb executive on a standard low-calorie diet, the research-supported minimum for muscle preservation during weight loss is approximately 1.2–1.6 grams of protein per kilogram of ideal body weight per day. On a GLP-1-suppressed appetite, hitting 0.8g/kg becomes a challenge. At that level, the body is in net muscle catabolism — dismantling structural tissue to meet metabolic demand.

"Your medication is suppressing your appetite so effectively that you're not eating enough protein to keep the muscle you're working so hard to build. The medication and the training are working against each other." — Danny Trejo, CES

Gastroparesis and Pre-Workout Nutrition. GLP-1s slow gastric emptying — this is a primary mechanism of their satiety effect. The clinical term is gastroparesis: food moves through the stomach more slowly than normal. The practical consequence is that pre-workout nutrition must be fundamentally rethought. Eating a meal 90 minutes before training — standard practice in conventional programming — can produce significant nausea when gastric motility is slowed. Timing and texture of pre-workout nutrition must be adapted to the GLP-1 patient's specific gastric motility pattern.

Reduced Power Output and CNS Fatigue. Energy availability is reduced on a GLP-1-mediated caloric deficit. Absolute power output — the ability to generate force quickly — decreases. Recovery between sets is slower. CNS fatigue accumulates faster. A training program that doesn't account for these changes will consistently push the GLP-1 patient into overreaching, which is catabolic, injury-producing, and ultimately discouraging.

What Standard Trainers Get Wrong

Common Error 01
Too Much Cardio

The instinct, when a patient is losing weight, is to add cardio to "accelerate the deficit." On a GLP-1 patient already running a significant caloric deficit, high-volume steady-state cardio is catabolic — it consumes lean mass as fuel. Cardio volume must be strictly controlled and used for cardiovascular adaptation, not caloric expenditure.

Common Error 02
Progressive Overload Without Energy Accounting

Progressive overload — incrementally increasing training load — is the foundation of strength adaptation. But progressive overload assumes adequate energy availability to support recovery. On a GLP-1-mediated deficit, pushing load upward without tracking energy status leads to overreaching, chronic fatigue, and injury risk — not adaptation.

Common Error 03
Ignoring Nausea Timing

GLP-1 nausea is worst in the first hours after injection and in the first weeks of dose escalation. Scheduling intense training sessions during peak nausea windows — or failing to adjust pre-workout nutrition for gastroparesis — creates a miserable experience that accelerates program dropout. Nausea windows must be mapped and trained around.

Common Error 04
Neglecting Protein Tracking

Most personal trainers are not nutrition professionals and are not tracking client protein intake. On a GLP-1 patient, this is a critical omission. Without active protein monitoring and supplementation strategy, the client will be building a training stimulus that cannot be recovered from — burning muscle to fuel the recovery it was supposed to be building.

The RxFit GLP-1 Adapted Protocol

RxFit's GLP-1 Adapted Protocol was developed specifically to address the training challenges of patients on semaglutide and tirzepatide. It operates across four integrated components:

  1. Training Timing: The Post-Nausea Window

    We map each client's nausea profile against their injection schedule and dose escalation timeline. Training sessions are scheduled in the post-nausea window — typically 48–72 hours post-injection for most patients. We do not train during peak nausea periods. We adapt as the patient's nausea pattern changes with dose adjustments.

  2. Eccentric Emphasis for Muscle Retention

    Eccentric loading — the controlled lowering phase of a lift — generates the highest mechanical tension for muscle retention at the lowest metabolic cost. On a GLP-1 patient with reduced energy availability, eccentric emphasis protocols achieve a muscle-preserving stimulus without the catabolic metabolic demand of high-volume, high-intensity training. We build programs around slow eccentrics, isometric holds, and controlled tempo.

  3. Protein-Forward Nutrition Strategy

    In coordination with your nutrition plan, we set explicit daily protein targets (minimum 1.2g/kg ideal body weight) and build a supplementation strategy around your GLP-1-suppressed appetite. Liquid protein sources, MCT-based shakes, and texture-modified options are used to hit targets when solid food intake is limited by gastroparesis or nausea. Every client's protein compliance is tracked session to session.

  4. Physician Coordination

    RxFit coordinates with your prescribing physician as part of the onboarding process. We share training load parameters, track objective performance markers (grip strength, HRV, subjective fatigue ratings), and flag any signals that warrant clinical attention. We are part of your care team, not a separate track.

Questions to Ask Your Trainer if You're on GLP-1s

If you are currently working with a trainer on GLP-1 medication — or are considering starting — use this checklist to evaluate whether your training program is adapted to your biology:

  • Are they tracking your daily protein intake? If not, they are missing the most critical variable in GLP-1 body composition management.
  • Do they know when you take your injection and when your nausea peaks? Training during peak nausea windows is a failure of program design, not your body.
  • Are they adjusting load for your energy availability? Progressive overload without energy accounting is overreaching — not progress.
  • Is the program emphasizing eccentric and isometric work? High-volume, high-intensity training on a GLP-1 deficit accelerates muscle loss, not retention.
  • Are they in communication with your prescribing physician? Your trainer and your doctor should be on the same team. If they're not talking, critical information is being siloed.
  • Are they tracking objective markers like grip strength and HRV? Subjective self-report is insufficient in a GLP-1 patient. Objective markers flag overreaching and muscle loss before they become clinical problems.

Working Alongside Your Physician

GLP-1 therapy is a clinical intervention. It requires physician oversight, regular monitoring, and dose management that is beyond the scope of personal training. RxFit does not replace that clinical relationship — we extend it.

ResponsibilityYour PhysicianRxFit
Prescription & DosingPrimary responsibility — dose titration, monitoring labs, managing side effectsNot applicable — outside scope of training practice
Body CompositionMonitors weight, BMI, metabolic markersTracks lean mass preservation, strength, HRV, grip strength
Nutrition StrategyGeneral guidance, caloric targetsProtein-forward implementation, GLP-1-adapted meal timing, supplementation
Training LoadGeneral "stay active" recommendationClinically adapted programming — nausea-timed, eccentric-focused, energy-accounted
CommunicationReceives flagged concerns from RxFitShares objective training data with prescribing physician at client consent

The physician manages the medication. RxFit manages the training and lifestyle variables that determine whether that medication produces the outcome you want — a leaner, stronger body — or the outcome nobody wants: less weight on the scale, less muscle on the frame, and a metabolic rate that is slower than when you started.

GLP-1 therapy is an extraordinary tool. The protocol surrounding it determines whether you use it to build a better body or simply a smaller one.

Danny Trejo
// About the Author
Danny Trejo
Corrective Exercise Specialist · Founder, RxFit Austin

Danny Trejo is the founder of RxFit, where he combines his background in microbiology with a passion for human performance. After years in the corporate world, he developed a comprehensive wellness system designed to help clients feel younger, stronger, and pain-free. His mission is to empower people to move better, age slower, and live fully.

View Full Profile